Transwell assays further showed that knockdown of NF90, NF110 or ILF3 inhibited migration of breast cancer cells (Figure 6C and 6D), and ecto-expression of NF90 or NF110 promoted migration of breast cancer cells (Figure 6E and 6F). Here, ILF3 is linked to breast carcinoma.